What is the recommended dosing for Sudafed (pseudoephedrine) for nasal and chest congestion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sudafed (Pseudoephedrine) Dosing for Nasal and Chest Congestion

For adults and children 12 years and older, take 60 mg (2 tablets of 30 mg) every 4-6 hours, not exceeding 240 mg (8 tablets) in 24 hours; children ages 6-11 should take 30 mg (1 tablet) every 4-6 hours, not exceeding 120 mg (4 tablets) in 24 hours. 1

Standard Dosing Regimen

Adults and children ≥12 years:

  • 60 mg every 4-6 hours (standard formulation contains 30 mg per tablet, so take 2 tablets per dose) 1
  • Maximum daily dose: 240 mg (8 tablets) in 24 hours 1
  • This 60 mg dose provides maximal nasal decongestion without cardiovascular effects 2

Children 6-11 years:

  • 30 mg every 4-6 hours (1 tablet per dose) 1
  • Maximum daily dose: 120 mg (4 tablets) in 24 hours 1

Children under 6 years:

  • Do not use 1

Clinical Efficacy

  • Pseudoephedrine 60 mg is the optimal single adult dose, achieving maximal nasal decongestion through vasoconstriction without cardiovascular or other unwanted effects 2
  • Efficacy is demonstrated by both objective measures (reduced nasal airway resistance) and subjective symptom improvement within hours of administration 3
  • The decongestant effect begins within 1 hour and persists for 4-6 hours, supporting the every 4-6 hour dosing interval 3, 2

Important Safety Considerations

Use with extreme caution or avoid in patients with:

  • Hypertension, cardiovascular disease, cerebrovascular disease, or angina 4, 5, 6
  • Cardiac arrhythmias 5
  • Hyperthyroidism 4
  • Closed-angle glaucoma 4
  • Bladder neck obstruction or prostatic hypertrophy 4

Cardiovascular effects:

  • Doses of 120 mg and 180 mg produce small but statistically significant increases in pulse rate (2-4 beats per minute) and systolic blood pressure 3, 2
  • The 60 mg dose does not produce significant cardiovascular effects 2
  • Severe cardiovascular events (including angina) can occur even at low doses and in patients without pre-existing pathology 6, 7

Other side effects:

  • Insomnia, irritability, and palpitations may occur 4, 5
  • Avoid concurrent use with caffeine or other stimulants, which may increase adverse effects 8

Clinical Pearls

  • For allergic rhinitis with congestion, intranasal corticosteroids are more effective than oral decongestants and should be considered first-line therapy 5
  • For acute congestion from common cold, pseudoephedrine is appropriate for short-term symptomatic relief 3
  • Combination therapy with an antihistamine (such as desloratadine or diphenhydramine) plus pseudoephedrine provides enhanced relief of nasal congestion compared to either agent alone 8, 9
  • Duration of use: While effective for multiple days, limit use to the shortest duration necessary given cardiovascular risks 7
  • Topical decongestants (such as oxymetazoline) provide more rapid relief but should be limited to 3-5 days maximum to avoid rebound congestion 5

Common Pitfalls to Avoid

  • Do not exceed recommended doses, as higher doses (120-180 mg) increase cardiovascular risks without improving decongestant efficacy 2
  • Do not use in children under 6 years of age 1
  • Monitor blood pressure in patients with hypertension, as even therapeutic doses can cause small increases 5, 3
  • Be aware that severe adverse events can occur unpredictably, even in patients without known risk factors 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment Options for Nasal Congestion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants.

European annals of otorhinolaryngology, head and neck diseases, 2015

Guideline

Polyhist Forte D Dosage and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.